Effects of Powerlifting-Based Training in Athletes
PLBT-ATH
The Effects of Powerlifting-Based Training on Hormonal, Metabolic, and Lipid Profile Parameters in Athletes: A Randomized Controlled Trial
1 other identifier
interventional
30
1 country
2
Brief Summary
This randomized controlled trial aims to examine the effects of a weightlifting-based training program on hormonal, metabolic, and lipid profile parameters in athletes. Participants will be randomly assigned to either a weightlifting-based training group or a control group. The training program will be implemented for a specific period, and relevant blood parameters will be evaluated before and after the intervention. The findings of this study may contribute to a better understanding of the physiological effects of weightlifting-based training on athletes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2025
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2025
CompletedFirst Submitted
Initial submission to the registry
December 29, 2025
CompletedFirst Posted
Study publicly available on registry
February 9, 2026
CompletedFebruary 9, 2026
January 1, 2026
5 months
December 29, 2025
February 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Mean Change in Fasting Serum Total Testosterone Concentration Measured by ELISA (ng/dL)
Mean difference between baseline and post-intervention fasting serum total testosterone concentrations, measured from venous blood samples using a commercially available enzyme-linked immunosorbent assay (ELISA).
Baseline and post-intervention (8 weeks)
Mean Change in Fasting Serum Cortisol Concentration Measured by ELISA (µg/dL)
Mean difference between baseline and post-intervention fasting serum cortisol concentrations, measured from venous blood samples using a commercially available enzyme-linked immunosorbent assay (ELISA).
Baseline and post-intervention (8 weeks)
Mean Change in Fasting Serum Growth Hormone Concentration Measured by ELISA (ng/mL)
Mean difference between baseline and post-intervention fasting serum growth hormone concentrations, measured from venous blood samples using a commercially available enzyme-linked immunosorbent assay (ELISA).
Baseline and post-intervention (8 weeks)
Mean Change in Fasting Serum Thyroid-Stimulating Hormone Concentration Measured by ELISA (µIU/mL)
Mean difference between baseline and post-intervention fasting serum thyroid-stimulating hormone concentrations, measured from venous blood samples using a commercially available enzyme-linked immunosorbent assay (ELISA).
Baseline and post-intervention (8 weeks)
Mean Change in Fasting Serum Triiodothyronine Concentration Measured by ELISA (ng/dL)
Mean difference between baseline and post-intervention fasting serum triiodothyronine concentrations, measured from venous blood samples using a commercially available enzyme-linked immunosorbent assay (ELISA).
Baseline and post-intervention (8 weeks)
Mean Change in Fasting Serum Thyroxine Concentration Measured by ELISA (µg/dL)
Mean difference between baseline and post-intervention fasting serum thyroxine concentrations, measured from venous blood samples using a commercially available enzyme-linked immunosorbent assay (ELISA).
Baseline and post-intervention (8 weeks)
Secondary Outcomes (6)
Mean Change in Fasting Serum Insulin Concentration Measured by ELISA (µIU/mL)
Baseline and post-intervention (8 weeks)
Mean Change in Fasting Blood Glucose Concentration Measured by Automated Biochemical Analyzer (mg/dL)
Baseline and post-intervention (8 weeks)
Mean Change in Total Cholesterol Concentration Measured by Automated Biochemical Analyzer (mg/dL)
Baseline and post-intervention (8 weeks)
Mean Change in Low-Density Lipoprotein Cholesterol Concentration Measured by Automated Biochemical Analyzer (mg/dL)
Baseline and post-intervention (8 weeks)
Mean Change in High-Density Lipoprotein Cholesterol Concentration Measured by Automated Biochemical Analyzer (mg/dL)
Baseline and post-intervention (8 weeks)
- +1 more secondary outcomes
Study Arms (2)
Powerlifting-Based Training Group
EXPERIMENTALParticipants performed a structured powerlifting-based training program in addition to their regular basketball training. The intervention was conducted three days per week for six weeks. Each session lasted approximately 60 minutes and included a standardized warm-up, a powerlifting-focused main training phase, and a cool-down period. The training program emphasized the squat, bench press, and deadlift exercises performed with progressive intensity. Accessory exercises targeting lower-body strength, upper-body musculature, and core stability were included. High-intensity bodyweight exercises were also performed to enhance anaerobic capacity and neuromuscular performance. All training sessions were supervised by qualified staff.
Control Group
OTHERParticipants continued their usual basketball training routines throughout the study period without any additional strength or powerlifting-based exercises.
Interventions
Participants will perform a structured powerlifting-based training program including squat, bench press, and deadlift exercises, conducted 3 sessions per week for 8 weeks under supervision.
Participants continued their usual basketball training routines without any additional strength or powerlifting-based exercises.
Venous blood samples were collected from participants at baseline and post-intervention following an overnight fast. Hormonal parameters were analyzed using ELISA methods, and metabolic and lipid profile parameters were analyzed using an automated biochemical analyzer.
Eligibility Criteria
You may qualify if:
- Male basketball players aged 18 to 24 years
- At least two years of regular sports experience
- Actively participating in basketball training and competition
- Voluntary participation with written informed consent
You may not qualify if:
- History of musculoskeletal injury or surgery within the last six months
- Presence of chronic disease or metabolic disorder
- Use of performance-enhancing drugs or hormonal supplements
- Participation in another structured training program during the study period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ramazan Erdoğanlead
Study Sites (2)
Faculty of Sport Sciences
Tunceli, Center, 62000, Turkey (Türkiye)
Munzur University
Bitlis, Tunceli, 62000, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 29, 2025
First Posted
February 9, 2026
Study Start
January 10, 2025
Primary Completion
June 15, 2025
Study Completion
October 15, 2025
Last Updated
February 9, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to ethical restrictions, participant confidentiality concerns, and the absence of participant consent for data sharing beyond the scope of this study.